<DOC>
	<DOCNO>NCT02080377</DOCNO>
	<brief_summary>The aim open label feasibility study determine recruitment rate randomise trial glibenclamide compare insulin ( addition maximum tolerate metformin ) treatment Gestational Diabetes Mellitus ( GDM ) . This feasibility trial inform design future substantive multicentre trial test hypothesis combination therapy glibenclamide metformin could reduce number pregnant woman GDM require insulin would superior metformin insulin term acceptability cost effectiveness . Women GDM `` fail '' monotherapy metformin recruit randomise either receive glibenclamide ( test arm ) standard care insulin , addition maximum tolerate dose metformin . Patients recruit three antenatal clinic . This feasibility study preparation large multicentre randomise trial test hypothesis addition glibenclamide metformin ( combination therapy ) could reduce number pregnant woman gestational diabetes mellitus require insulin , without compromise glycaemic control clinical outcome . The investigator hypothesise combination therapy metformin glibenclamide likely preferable metformin insulin term acceptability cost .</brief_summary>
	<brief_title>A Feasibility Study Looking Use Glibenclamide metfoRmin Versus stAndard Care gEstational diabeteS</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Pregnant woman diagnose gestational diabetes fail achieve `` adequate glycaemic control '' maximum tolerate dose metformin Inadequate glycaemic control define accord SIGN 116 guideline . Pregnant woman require insulin prior 20 week gestation 36 week gestation . Pregnant woman take least 500mg metformin daily . Patients suspect Type 1 diabetes mellitus present pregnancy . Women allergies either glibenclamide insulin excipients . Women contraindication sulfonylurea therapy . Women unable give inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Gestational diabetes</keyword>
	<keyword>Glycaemic control</keyword>
	<keyword>Metformin</keyword>
</DOC>